Search Results for 'Clinical-Endpoints'

Clinical-Endpoints published presentations and documents on DocSlides.

Clinical/Surrogate Endpoints and Innovative Approaches for Catheter Ablation Studies
Clinical/Surrogate Endpoints and Innovative Approaches for Catheter Ablation Studies
by SugarPlumFairy
FDA Perspective. Marco Cannella, PhD. Senior Lead ...
Positive Impacts of Developing Novel Endpoints
Positive Impacts of Developing Novel Endpoints
by ryotheasy
Generated by Mobile Technology for . Use in Clinic...
Pragmatic Clinical Trials:   Challenges with Clinical Event Ascertainment using
Pragmatic Clinical Trials: Challenges with Clinical Event Ascertainment using
by anastasia
RWD. Frank W. Rockhold, PhD. Professor of Biostati...
Pain, Distress and Humane Endpoints
Pain, Distress and Humane Endpoints
by phoebe-click
Stephanie Cook. Rachel Feldman. Noel Ramsey. Cody...
Pain, Distress and Humane Endpoints
Pain, Distress and Humane Endpoints
by tatiana-dople
Context. Module intended for seasoned IACUC membe...
Session I: DHT-Derived Novel Endpoint Development: Current Landscape
Session I: DHT-Derived Novel Endpoint Development: Current Landscape
by deborah
Elektra Papadopoulos, . FDA/CDER. Lindsay Kehoe, ....
End-points utilized in  breast cancer
End-points utilized in breast cancer
by evelyn
clinical . trials - Discussion. Novartis Oncology...
Regulatory aspects and  review
Regulatory aspects and review
by mary
of EMA authorized . biosimilars. Session “Biosim...
Wound Care Collaborative Community
Wound Care Collaborative Community
by clara
Member Meeting January 4, 2022. 0. Agenda- . Welc...
Analysis of Multiple End Points in Clinical trials
Analysis of Multiple End Points in Clinical trials
by roberts
. By . Trusha Patel and Sirisha . Davuluri. “An ...
End-points utilized in
End-points utilized in
by marina-yarberry
End-points utilized in breast cancer clinical ...
Processing Aggregate Queries in a Federation of
Processing Aggregate Queries in a Federation of
by briana-ranney
SPARQL Endpoints. Dilshod IBRAGIMOV, KATJA HOSE, ...
Clipping
Clipping
by myesha-ticknor
CSCI 440. textbook section 8.3-8.7. Starter Quest...
Exploration of Endpoints for Pivotal Clinical Trials to Treat AUD
Exploration of Endpoints for Pivotal Clinical Trials to Treat AUD
by victoria
Raye Z. Litten, Ph.D.. Daniel Falk, Ph.D. (Discuss...
Advanced Biostatistics & Statistical Programming Solutions for Clinical Research
Advanced Biostatistics & Statistical Programming Solutions for Clinical Research
by Pubrica106
We provide expert Biostatistical programming servi...
Biostatistics & Clinical Trial Programming Services | Pubrica
Biostatistics & Clinical Trial Programming Services | Pubrica
by Pubrica106
Pubrica delivers Biostatistical programming servic...
Critical Issues in the Exploration of Endpoints for Pivotal Clinical Trials to Treat AUD
Critical Issues in the Exploration of Endpoints for Pivotal Clinical Trials to Treat AUD
by byrne
Daniel Falk, Ph.D. (Discussant). Division of Treat...
Denise A. Yardley, MD Sarah Cannon Research Institute
Denise A. Yardley, MD Sarah Cannon Research Institute
by lily
Senior Investigator, . Breast Cancer Research. Ten...
Biomarkers A   biological marker is
Biomarkers A   biological marker is
by madison
a measurable indicator . that . can . tell . us so...
“Stronger Together We are”
“Stronger Together We are”
by faustina-dinatale
Daniel J. Sargent, PhD. 1970-2016. Wore Many hats...
Clinical 101: Clinical trial endpoints:
Clinical 101: Clinical trial endpoints:
by sherrill-nordquist
Selection. , analysis and interpretation. Elizabe...
Thierry Le Chevalier, MD
Thierry Le Chevalier, MD
by aaron
How . d. o . International Regulatory Groups View...
Exploration of Endpoints for Pivotal Clinical Trials to Tre
Exploration of Endpoints for Pivotal Clinical Trials to Tre
by yoshiko-marsland
Raye Z. Litten, Ph.D.. Daniel Falk, Ph.D. (Discus...
Three-year clinical and echocardiographic follow-up of aort
Three-year clinical and echocardiographic follow-up of aort
by briana-ranney
Sabine . Bleiziffer. . German Heart Center, Muni...
Thierry Le Chevalier, MD
Thierry Le Chevalier, MD
by yoshiko-marsland
How . d. o International Regulatory Groups View C...
Advanced Research Services for Medical & Scientific Writing Excellence
Advanced Research Services for Medical & Scientific Writing Excellence
by Pubrica106
We offer scientific research writing services, med...
Medical Thesis & Dissertation Writing Experts | Pubrica
Medical Thesis & Dissertation Writing Experts | Pubrica
by Pubrica106
Pubrica provides medical thesis dissertation writi...
Introduction, Meeting Objectives and roadmap
Introduction, Meeting Objectives and roadmap
by jaxson
Roy Freeman, MD. Professor of Neurology, Harvard M...
Center for Drug Evaluation and Research CDER ClinicalMedical
Center for Drug Evaluation and Research CDER ClinicalMedical
by pagi
Additional copies are available from: Office of Co...
White Paper S
White Paper S
by harmony
trengthening the Accelerated Approval Pathway1STRE...
Digital Health Learning & Clinical Effectiveness Research Collaboratives
Digital Health Learning & Clinical Effectiveness Research Collaboratives
by acenum
May 22, 2019. Journal Editor Perspectives. Joseph ...
Statistical issues:
Statistical issues:
by conchita-marotz
Designing your trial for success. Elizabeth Garre...
Results of DEFUSE  Clinical Endpoints International St
Results of DEFUSE Clinical Endpoints International St
by natalia-silvester
Lansberg MD PhD No Relevant Disclosures On behalf...
Guidelines for Endpoints in Animal Study ProposalsIntroductionEndpoint
Guidelines for Endpoints in Animal Study ProposalsIntroductionEndpoint
by briana-ranney
1 2 Clinical observations used in cancer research ...
Accessing the Accelerated Approval Pathway with a Rare Neur
Accessing the Accelerated Approval Pathway with a Rare Neur
by karlyn-bohler
Batten Disease. June 29-30, 2010 . FDA Public Mee...
Rationale for New Drugs for Tuberculosis
Rationale for New Drugs for Tuberculosis
by pamella-moone
500,000 cases annually of MDR TB. Second line tre...